Hypothalamic-pituitary-adrenal axis in methadone-treated heroin addicts.
D015065:17-Hydroxycorticosteroids / Q000097:blood; D000328:Adult; D002986:Clinical Trials as Topic; D003346:Corticotropin-Releasing Hormone / Q000502:physiology; D005246:Feedback; D005938:Glucocorticoids / Q000652:urine; D003932:Heroin; D006801:Humans; D007003:Hypoglycemia / Q000139:chemically induced; D007030:Hypothalamo-Hypophyseal System / Q000503:physiopathology*; D007328:Insulin; D008297:Male; D008691:Methadone / Q000627:therapeutic use*; D008797:Metyrapone; D008875:Middle Aged; D010507:Periodicity; D010913:Pituitary-Adrenal System; D013312:Stress, Physiological; D019966:Substance-Related Disorders / Q000188:drug therapy*
D015065:17-Hydroxycorticosteroids; D005938:Glucocorticoids; D007328:Insulin; D003932:Heroin; D003346:Corticotropin-Releasing Hormone; D008691:Methadone; D008797:Metyrapone